Online Referral Programs, Telehealth, and Other OIG Hot Topics
The Trump II Administration is active in terms of regulating…and placing restrictions on…DME suppliers. Prime examples of these are OIG advisory opinions, fraud alerts, advisory bulletins and other written guidance. This program will discuss the most recent OIG guidance on issues vitally important to DME suppliers, including (i) subscribing to online referral programs, (ii) working with telehealth companies, (iii) joint ventures and other contracts with hospitals, long-term care facilities, and other referral sources, (iv) implementation of marketing programs, and (v) strategic relationships with physicians. Importantly, in light of OIG guidance, this program will discuss how arrangements and programs can be properly structured…and those that lead to a risk of an OIG enforcement action.

